首页> 外文期刊>Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology >The effect of metabolic syndrome and obesity on outcomes of acute ischemic stroke patients treated with systemic thrombolysis
【24h】

The effect of metabolic syndrome and obesity on outcomes of acute ischemic stroke patients treated with systemic thrombolysis

机译:代谢综合征及肥胖对全身溶栓治疗急性缺血性脑卒中患者结果的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Metabolic syndrome (MetS) is associated with increased risk of ischemic stroke; while central obesity has controversial effects on ischemic stroke. We investigated effects of MetS and obesity on clinical courses and outcomes of patients treated with intravenous recombinant tissue-type plasminogen activator (iv rt-PA). 319 patients treated with intravenous thrombolysis were included to our study. Metabolic syndrome was determined if ≥3 of following criteria are present: elevated waist circumference; elevated triglycerides; reduced high density-lipoprotein cholesterol (HDL-C); elevated blood pressure; elevated fasting glucose. Obesity was defined as BMI≥30. Clinical features at baseline, 24th hour and 3rd month were examined. Computed tomography (CT) findings for ASPECT scores and hemorrhagic transformation were analyzed. 182 patients were MetS+; they were older ( p = 0.035 ), had similar ASPECT scores ( p = 0.477 ) and NIHSS scores ( p = 0.167 ) at admission; had significantly higher NIHSS scores at 24th hour ( p 0.001 ) and worse outcome at 3rd month ( p 0.001 ). Logistic regression analysis showed that either MetS, obesity or age were not independent predictors of poor outcome. Obese patients (n:72) had slight but significantly lower NIHSS scores at admission ( p = 0.049 ) compared to non-obese patients; meanwhile there was no significant difference between NIHSS scores at 24th hour ( p = 0.736 ) and 3rd month mRS scores ( p = 0.145 ). Hemorrhagic transformation and mortality rates were not affected with MetS or obesity. MetS is not an independent factor on clinical outcome but its presence may have a relationship with poor outcome; but obesity was not found to have any significant role on clinical course and outcome of patients treated with iv rt-PA. Highlights ? In acute ischemic stroke patients treated with iv rt-PA MetS may be associated with poor outcome, but not an independent factor.
机译:摘要代谢综合征(Mets)与缺血性卒中的风险增加有关;虽然中央肥胖对缺血性卒中具有争议作用。我们调查了Mets和肥胖对静脉注射重组组织型纤溶酶原激活剂(IV RT-PA)治疗的患者临床疗养和结果的影响。在我们的研究中包括319例治疗静脉溶栓治疗的患者。确定≥3的标准是否确定代谢综合征:腰围升高;纯甘油三酯;降低高密度 - 脂蛋白胆固醇(HDL-C);血压升高;升高的空腹葡萄糖。肥胖被定义为BMI≥30。检查基线,第24小时和第3个月的临床特征。分析了各个方面评分和出血性转化的计算断层扫描(CT)结果。 182名患者+;它们较旧(P = 0.035),在入院时具有类似的方面得分(P = 0.477)和NIHSS分数(P = 0.167);在第24小时(p 0.001)的NIHSS分数明显高出较高(P <0.001),第3个月的结果差(p 0.001)。逻辑回归分析表明,大都会,肥胖症或年龄都不是独立的预测因素。与非肥胖患者相比,肥胖患者(N:72)略微但显着降低NIHSS评分(P = 0.049);同时,第24小时的NIHSS分数之间没有显着差异(p = 0.736)和第3个月S分数(P = 0.145)。出血性转化和死亡率不受大都会或肥胖的影响。 Mets不是临床结果的独立因素,但它的存在可能与结果差的关系;但没有发现肥胖在患有IV RT-PA治疗的患者的临床课程中具有任何重要作用。强调 ?在急性缺血性脑卒中患者中,患有IV RT-PA METS的患者可能与结果不良,但不是一个独立的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号